Carlos Arteaga

Carlos Arteaga, M.D., is a Professor of Internal Medicine and the Director of the Simmons Comprehensive Cancer Center at UT Southwestern Medical Center. He also serves as Associate Dean of Oncology Programs and holds the Annette Simmons Distinguished University Chair in Breast Cancer Research. Prior to joining UT Southwestern in 2017, he led the Breast Cancer Program at Vanderbilt University, where he directed translational research initiatives.

• Medical Degree: University of Guayaquil, Ecuador
• Residency: Emory University (Internal Medicine)
• Fellowship: University of Texas Health Science Center San Antonio (Medical Oncology)

Dr. Arteaga is a global authority in breast cancer, with over 350 publications focusing on oncogenes, tumor progression, targeted therapies, and clinical trial design. His work explores mechanisms of drug resistance, such as HER2 mutations and PRMT5 pathways, and emphasizes biomarker discovery for personalized treatment.

Recent publications highlight his leadership in precision oncology trials (e.g., NCI-MATCH) and collaborative frameworks like the AACR Cancer Centers Alliance, which he co-authored to advance cross-institutional research. Key studies address therapies for FGFR/HER2 mutations and metabolic dependencies in metastatic breast cancer.

• AACR Richard & Hinda Rosenthal Award
• American Cancer Society Clinical Research Professor (2007-2017)
• Gianni Bonadonna Award (ASCO, 2009)
• Brinker Award (Susan G. Komen, 2011)
• Prize for Scientific Excellence (American-Italian Cancer Foundation, 2015)

His research is supported by the National Cancer Institute, American Cancer Society, Department of Defense Breast Cancer Program, Stand Up 2 Cancer, Susan G. Komen, and industry partnerships. Dr. Arteaga has chaired the San Antonio Breast Cancer Symposium since 2009 and served as AACR President (2014-15).